Project Call 10.1
Project Call 10.1 supports industry, research institutions, community colleges, and nonprofits in technology and workforce collaborations to strengthen U.S. biopharmaceutical manufacturing.
Funder: National Institute for Innovation in Manufacturing Biopharmaceuticals
Due Dates: September 9, 2026, 5 pm ET (Concept paper) | November 30, 2026, 5 pm EST (Delaware cost-share request) | January 7, 2027, 5 pm ET (Full proposal)
Funding Amounts: Up to $500,000 per proposal for up to 12 months; minimum 1:1 non-federal cost share
Summary: Supports collaborative technology and workforce development projects that strengthen U.S. competitiveness in biopharmaceutical manufacturing.
Key Information: Full proposals are invitation-only and require at least two distinct NIIMBL member organizations.
Description
NIIMBL’s Project Call 10.1 supports industry-led technology and workforce development collaborations addressing biopharmaceutical manufacturing challenges. Technology priorities encompass intelligent biomanufacturing through artificial intelligence, digitalization, and advanced process control; advanced process analytics and real-time quality control; manufacturing platforms and process intensification; emerging biotherapeutic platforms; and transformative technologies for the future biomanufacturing enterprise.
Workforce priorities focus on cross-regional collaboration, training for advanced therapeutic modalities, and digital fluency. Projects can scale proven workforce models, assess emerging skills needs, develop hands-on education, or create shareable digital training resources. The call brings industry, research institutions, community colleges, and nonprofits together to advance manufacturing capabilities and training aligned with industry needs.
